• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮处理心血管植入式电子设备患者的上腔静脉综合征。

Percutaneous management of superior vena cava syndrome in patients with cardiovascular implantable electronic devices.

机构信息

Department of Electrophysiology, North Shore University Hospital, Northwell Health, Manhasset, New York.

Department of Electrophysiology, North Shore University Hospital, Northwell Health, Manhasset, New York.

出版信息

Heart Rhythm. 2021 Mar;18(3):392-398. doi: 10.1016/j.hrthm.2020.11.012. Epub 2020 Nov 17.

DOI:10.1016/j.hrthm.2020.11.012
PMID:33212249
Abstract

BACKGROUND

There is no consensus regarding the optimal management of cardiovascular implantable electronic device (CIED)-related superior vena cava (SVC) syndrome.

OBJECTIVE

We report our experience with transvenous lead extractions (TLEs) in the setting of symptomatic CIED-related SVC syndrome.

METHODS

We reviewed all TLEs performed at a high-volume center over a 14-year period and identified patients in which TLE was performed for symptomatic SVC syndrome. Patient characteristics, extraction details, percutaneous management of SVC occlusions, and clinical follow up data were analyzed.

RESULTS

Over a 14-year period, more than 1600 TLEs were performed. Of these, 16 patients underwent TLE for symptomatic SVC syndrome. The mean age was 53.1 ± 12.8 years, and 9 (56.3%) were men. Thirty-seven leads, with a mean dwell time of 5.8 years (range 2-12 years), were extracted. After extraction, 6 patients (37.5%) received an SVC stent. Balloon angioplasty was performed before stenting in 5 cases (31.3%). There was 1 major complication (6.3%) due to an SVC tear that was managed surgically with a favorable outcome. Eleven patients underwent reimplantation of a CIED. Over a median follow-up of 5.5 years (interquartile range 2.0-8.5 years), 12 patients (75%) remained free of symptoms.

CONCLUSION

Combining TLE with the percutaneous treatment of symptomatic SVC syndrome is a safe and viable treatment strategy.

摘要

背景

目前对于心血管植入式电子设备(CIED)相关上腔静脉(SVC)综合征的最佳治疗方法尚无共识。

目的

我们报告了在有症状的 CIED 相关 SVC 综合征患者中经静脉导线拔除术(TLE)的经验。

方法

我们回顾了一家高容量中心在 14 年期间进行的所有 TLE,并确定了因 SVC 综合征症状而行 TLE 的患者。分析了患者特征、拔除细节、SVC 闭塞的经皮处理以及临床随访数据。

结果

在 14 年期间,进行了超过 1600 次 TLE。其中,16 例因 SVC 综合征症状而行 TLE。平均年龄为 53.1±12.8 岁,9 例(56.3%)为男性。拔除了 37 根导线,平均留置时间为 5.8 年(范围 2-12 年)。拔除后,6 例(37.5%)患者接受了 SVC 支架治疗。在支架植入前,有 5 例(31.3%)患者进行了球囊血管成形术。有 1 例(6.3%)严重并发症,即 SVC 撕裂,经手术治疗后预后良好。11 例患者接受了 CIED 的重新植入。在中位数为 5.5 年(四分位间距 2.0-8.5 年)的随访中,12 例(75%)患者无症状。

结论

将 TLE 与 SVC 综合征的经皮治疗相结合是一种安全可行的治疗策略。

相似文献

1
Percutaneous management of superior vena cava syndrome in patients with cardiovascular implantable electronic devices.经皮处理心血管植入式电子设备患者的上腔静脉综合征。
Heart Rhythm. 2021 Mar;18(3):392-398. doi: 10.1016/j.hrthm.2020.11.012. Epub 2020 Nov 17.
2
Lead-related superior vena cava syndrome: Management and outcomes.铅相关性上腔静脉综合征:管理与结局。
Heart Rhythm. 2021 Feb;18(2):207-214. doi: 10.1016/j.hrthm.2020.09.006. Epub 2020 Sep 11.
3
Managing superior vena cava syndrome in patients with cardiac implantable electronic device leads: Strategies and considerations.心脏植入式电子设备导线患者上腔静脉综合征的管理:策略与考量
Heart Rhythm. 2025 Feb;22(2):311-317. doi: 10.1016/j.hrthm.2024.06.060. Epub 2024 Jul 3.
4
Percutaneous treatment of superior vena cava obstruction following transvenous device implantation.经静脉装置植入后上腔静脉阻塞的经皮治疗
Catheter Cardiovasc Interv. 2005 May;65(1):54-9. doi: 10.1002/ccd.20326.
5
Compliant endovascular balloon reduces the lethality of superior vena cava tears during transvenous lead extractions.顺应性血管内球囊降低了经静脉导线拔除术中上腔静脉撕裂的致死率。
Heart Rhythm. 2017 Sep;14(9):1400-1404. doi: 10.1016/j.hrthm.2017.05.005. Epub 2017 May 13.
6
Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up.经皮腔内血管内处理良性病因所致慢性上腔静脉综合征:长期随访。
Eur Radiol. 2017 Jan;27(1):97-104. doi: 10.1007/s00330-016-4354-y. Epub 2016 Apr 16.
7
[Superior vena cava thrombosis or stricture secondary to implanted central venous access: Six cases of endovascular and direct surgical treatment in cancer patients].[植入式中心静脉通路继发上腔静脉血栓形成或狭窄:癌症患者的6例血管内及直接手术治疗]
J Med Vasc. 2018 Feb;43(1):20-28. doi: 10.1016/j.jdmv.2017.11.001. Epub 2017 Dec 26.
8
Outcome and management of pacemaker-induced superior vena cava syndrome.起搏器所致上腔静脉综合征的结局与处理
Pacing Clin Electrophysiol. 2014 Nov;37(11):1470-6. doi: 10.1111/pace.12455. Epub 2014 Jul 17.
9
Endovascular Occlusion Balloon for Treatment of Superior Vena Cava Tears During Transvenous Lead Extraction: A Multiyear Analysis and an Update to Best Practice Protocol.血管内闭塞球囊治疗经静脉导线拔除术中上腔静脉撕裂:一项多年回顾分析及最佳实践方案更新。
Circ Arrhythm Electrophysiol. 2019 Aug;12(8):e007266. doi: 10.1161/CIRCEP.119.007266. Epub 2019 Aug 12.
10
Leadless pacemakers as a new alternative for pacemaker lead-related superior vena cava syndrome: A case report.无导线起搏器作为与起搏器导线相关的上腔静脉综合征的新替代方法:一例报告。
Pacing Clin Electrophysiol. 2022 Sep;45(9):1051-1055. doi: 10.1111/pace.14520. Epub 2022 Aug 1.

引用本文的文献

1
Joint Pacing and Vascular Intervention for the Management of Cardiac Device Associated Central Venous Obstruction.联合起搏与血管介入治疗心脏装置相关中心静脉阻塞
Pacing Clin Electrophysiol. 2025 Sep;48(9):959-966. doi: 10.1111/pace.70019. Epub 2025 Jul 31.
2
New Diseases Related to Cardiac Implantable Electronic Devices (CIEDs): An Overview.与心脏植入式电子设备(CIEDs)相关的新疾病:概述
J Clin Med. 2025 Feb 17;14(4):1322. doi: 10.3390/jcm14041322.
3
Newly Designed, Self-Expanding Large-Bore Nitinol Stents for Symptomatic Central Venous Stenosis: Technical and Long-Term Clinical Outcome.
新型自膨式大口径镍钛诺支架治疗症状性中心静脉狭窄:技术和长期临床结果。
Cardiovasc Intervent Radiol. 2024 Sep;47(9):1200-1209. doi: 10.1007/s00270-024-03820-y. Epub 2024 Aug 12.
4
A "one-step" treatment for symptomatic lead-related venous obstruction using percutaneous lead extraction, venous stenting, and new device implantation.一种针对有症状的铅相关静脉阻塞的“一站式”治疗方法,采用经皮导线拔除、静脉支架置入和新设备植入。
HeartRhythm Case Rep. 2024 Mar 15;10(6):394-397. doi: 10.1016/j.hrcr.2024.03.004. eCollection 2024 Jun.
5
Superior vena cava obstruction and cardiovascular implantable electronic devices-a new era of leadless devices.上腔静脉阻塞与心血管植入式电子设备——无导线设备的新时代。
Mediastinum. 2023 Dec 12;8:1. doi: 10.21037/med-23-33. eCollection 2024.
6
Successful treatment of lead-related superior vena cava syndrome in combination with transvenous lead extraction and venous stenting.经静脉导线拔除术联合静脉支架置入术成功治疗铅相关上腔静脉综合征
J Arrhythm. 2023 Sep 1;39(5):813-815. doi: 10.1002/joa3.12920. eCollection 2023 Oct.
7
Lead management in patients undergoing percutaneous tricuspid valve replacement or repair: a 'heart team' approach.经皮三尖瓣置换或修复术患者的导管理:一种“心脏团队”方法。
Europace. 2023 Nov 2;25(11). doi: 10.1093/europace/euad300.
8
Rocket-shape crossing technique: A combination of lead extraction and modified venoplasty for device upgrade with venous occlusion.火箭形交叉技术:一种用于装置升级并伴有静脉闭塞的导丝取出与改良静脉成形术的联合方法。
J Arrhythm. 2023 May 24;39(4):621-622. doi: 10.1002/joa3.12875. eCollection 2023 Aug.
9
Incidence, Treatment, and Outcomes of Symptomatic Device Lead-Related Venous Obstruction.有症状的器械相关静脉阻塞的发生率、治疗和结局。
J Am Coll Cardiol. 2023 Jun 20;81(24):2328-2340. doi: 10.1016/j.jacc.2023.04.017. Epub 2023 May 18.
10
New Insights in Central Venous Disorders. The Role of Transvenous Lead Extractions.中心静脉疾病的新见解。经静脉导线拔除的作用。
Front Cardiovasc Med. 2022 Feb 23;9:783576. doi: 10.3389/fcvm.2022.783576. eCollection 2022.